Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects von Arm, J. P., Bottoli, I., Skerjanec, A., Floch, D., Groenewegen, A., Maahs, S., Owen, C. E., Jones, I., Lowe, P. J.

Volltext

The clinical pharmacokinetics of darifenacin von SKERJANEC, Andrej

Volltext

Ob 150-letnici Vegovega rojstva

Volltext bestellen

A large multi-center, randomized, double-blind, crossover study in healthy volunteers to compare pharmacokinetics and pharmacodynamics of a proposed biosimilar pegfilgrastim with E... von Nakov, R., Schussler, S., Schier-Mumzhiu, S., Skerjanec, A., Bellon, A., Wang, J., Krendyukov, A., Otto, G.

Volltext

Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Bone Metastases von Chen, Tianling, Berenson, James, Vescio, Robert, Swift, Regina, Gilchick, Alicia, Goodin, Susan, LoRusso, Patricia, Ma, Peiming, Ravera, Christina, Deckert, Fabienne, Schran, Horst, Seaman, John, Skerjanec, Andrej

Volltext

307 Population pharmacokinetic and pharmacodynamic modeling of bevacizumab and a proposed biosimilar (GP2019) in healthy male volunteers von Elmeliegy, M, Potocka, E, Renard, D, Kakar, S, Skerjanec, A, Li, Y, Castro, H, Izquierdo, M, Barker, D

Volltext

Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys von Dudal, S, Subramanian, K, Flandre, T, Law, WS, Lowe, PJ, Skerjanec, A, Genin, J-C, Duval, M, Piequet, A, Cordier, A, Jarai, G, Van Heeke, G, Taplin, S, Krantz, C, Jones, S, Warren, AP, Brennan, FR, Sims, J, Lloyd, P

Volltext

The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function von Skerjanec, Andrej, Berenson, James, Hsu, ChyiHung, Major, Pierre, Miller Jr, Wilson H., Ravera, Christina, Schran, Horst, Seaman, John, Waldmeier, Felix

Volltext

Correlation of in vitro and in vivo paracetamol availability from layered excipient suppositories von Chicco, D., Grabnar, I., Škerjanec, A., Vojnovic, D., Maurich, V., Realdon, N., Ragazzi, E., Belič, A., Karba, R., Mrhar, A.

Volltext

Effect of age on the pharmacokinetics of duloxetine in women von Skinner, Michael H., Kuan, Han‐Yi, Skerjanec, Andrej, Seger, Mary E., Heathman, Michael, O'Brien, Lisa, Reddy, Shobha, Knadler, Mary P.

Volltext

QT and QTc Interval With Standard and Supratherapeutic Doses of Darifenacin, a Muscarinic M 3 Selective Receptor Antagonist for the Treatment of Overactive Bladder von Serra, Denise B., Affrime, Melton B., Bedigian, Martin P., Greig, Gerard, Milosavljev, Slavica, Skerjanec, Andrej, Wang, Yibin

Volltext

Abstract P3-14-10: Proposed biosimilar pegfilgrastim LA-EP2006 shows similarity in pharmacokinetics and pharmacodynamics to reference pegfilgrastim in healthy subjects von Nakov, R, Gattu, S, Wang, J, Velinova, M, Skerjanec, A

Volltext

Automated modelling of urban rainfall-runoff: knowledge library, conceptual model and data set von Matej Radinja

Volltext bestellen

Automated modelling of urban rainfall-runoff: knowledge library, conceptual model and data set von Matej Radinja

Volltext bestellen

1796PA large multi-center, randomized, double-blind, crossover study in healthy volunteers to compare pharmacokinetics and pharmacodynamics of a proposed biosimilar pegfilgrastim w... von Nakov, R, Schussler, S, Schier-Mumzhiu, S, Skerjanec, A, Bellon, A, Wang, J, Krendyukov, A, Otto, G

Volltext

Randomized, double-blind, cross-over phase I study comparing pharmacokinetics, pharmacodynamics, safety and immunogenicity of a biosimilar pegfilgrastim with EU and US references von Velinova, M., Bellon, A., Nakov, R., Schussler, S., Schier-Mumzhiu, S., Schelcher, C., Koch, S.D., Skerjanec, A., Wang, J., Krendyukov, A., Otto, G.P.

Volltext

1815PRandomized, double-blind, cross-over phase I study comparing pharmacokinetics, pharmacodynamics, safety and immunogenicity of a biosimilar pegfilgrastim with EU and US referen... von Velinova, M, Bellon, A, Nakov, R, Schussler, S, Schier-Mumzhiu, S, Schelcher, C, Koch, S D, Skerjanec, A, Wang, J, Krendyukov, A, Otto, G P

Volltext

1815P - Randomized, double-blind, cross-over phase I study comparing pharmacokinetics, pharmacodynamics, safety and immunogenicity of a biosimilar pegfilgrastim with EU and US refe... von Velinova, M., Bellon, A., Nakov, R., Schussler, S., Schier-Mumzhiu, S., Schelcher, C., Koch, S.D., Skerjanec, A., Wang, J., Krendyukov, A., Otto, G.P.

Volltext

Pharmacokinetic/pharmacodynamic relationships of FTY720 in kidney transplant recipients von Park, S I, Felipe, C R, Machado, P G, Garcia, R, Skerjanec, A, Schmouder, R, Tedesco-Silva, Jr, H, Medina-Pestana, J O

Volltext

First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients von BUDDE, Klemens, SCHMOUDER, Robert L, BRUNKHORST, Reinhard, NASHAN, Bjorn, LÜCKER, Peter W, MAYER, Thomas, CHOUDHURY, Somesh, SKERJANEC, Andrej, KRAUS, Gerolf, NEUMAYER, Hans H

Volltext